HUTCHMED (China) Ltd (HCM) stock
HCMNasdaqPharmaceutical PreparationsAlso trades as HMDCF
$14.40−0.33 (-2.24%)
Close on Nov 17, 2026Market cap $2.51BP/E 5.5Yield –
HUTCHMED (China) total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
HUTCHMED (China)'s total debt was $116.91M at Jun 30, 2026. For fiscal 2025 it was $118.13M, up 11.3% from the year before. Over ten years it grew 16.0% a year on average. The highest annual figure on record is $118.13M in fiscal 2025.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $118.13M | +11.3% |
| FY2024 | Dec 31, 2024 | $106.18M | -3.9% |
| FY2023 | Dec 31, 2023 | $110.50M | +510.4% |
| FY2022 | Dec 31, 2022 | $18.10M | -32.7% |
| FY2021 | Dec 31, 2021 | $26.91M | +0.2% |
| FY2020 | Dec 31, 2020 | $26.86M | +0.2% |
| FY2019 | Dec 31, 2019 | $26.82M | +0.3% |
| FY2018 | Dec 31, 2018 | $26.74M | -10.8% |
| FY2017 | Dec 31, 2017 | $29.99M | -35.9% |
| FY2016 | Dec 31, 2016 | $46.79M | +74.8% |
| FY2015 | Dec 31, 2015 | $26.77M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $116.91M | +7.7% |
| Q4 FY2025 | Dec 31, 2025 | $118.13M | +6.9% |
| Q2 FY2025 | Jun 30, 2025 | $119.05M | +196.5% |
| Q4 FY2024 | Dec 31, 2024 | $106.18M | +486.5% |
| Q2 FY2024 | Jun 30, 2024 | $108.57M | +25873.2% |
| Q4 FY2023 | Dec 31, 2023 | $110.50M | +310.7% |
| Q2 FY2023 | Jun 30, 2023 | $40.15M | +49.3% |
| Q4 FY2022 | Dec 31, 2022 | $18.10M | -32.6% |
| Q2 FY2022 | Jun 30, 2022 | $418.00K | -98.4% |
| Q4 FY2021 | Dec 31, 2021 | $26.91M | +0.3% |
| Q2 FY2021 | Jun 30, 2021 | $26.88M | +0.4% |
| Q4 FY2020 | Dec 31, 2020 | $26.86M | +0.5% |
| Q2 FY2020 | Jun 30, 2020 | $26.84M | +0.6% |
| Q4 FY2019 | Dec 31, 2019 | $26.82M | -10.6% |
| Q1 FY2019 | Mar 31, 2019 | $26.76M | -42.9% |
| Q4 FY2018 | Dec 31, 2018 | $26.74M | -42.8% |
| Q2 FY2018 | Jun 30, 2018 | $26.69M | -0.3% |
| Q4 FY2017 | Dec 31, 2017 | $29.99M | – |
| Q2 FY2017 | Jun 30, 2017 | $46.85M | – |
| Q4 FY2016 | Dec 31, 2016 | $46.79M | – |
| Q4 FY2015 | Dec 31, 2015 | $26.77M | – |
See a number that looks wrong?